ArticleSensors (Basel, Switzerland)2025
Citrus Disease Detection Based on Dilated Reparam Feature Enhancement and Shared Parameter Head.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- LCWG-DETR: a wavelet-enhanced detection transformer for citrus disease detection improving visual perception in harvesting.Frontiers in plant science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Accurate citrus disease identification is essential for targeted orchard pesticide application. Current models struggle with accuracy and efficiency due to diverse leaf lesion patterns and complex orchard environments. This study presents YOLOv8n-DE, an improved lightweight YOLOv8-based model for enhanced citrus disease detection. It introduces the DR module structure for effective feature enhancement and the Detect_Shared architecture for parameter efficiency. Evaluated on public and orchard-collected datasets, YOLOv8n-DE achieves 97.6% classification accuracy, 91.8% recall, and 97.3% mAP, with a 90.4% mAP for challenging diseases. Compared to the original YOLOv8, it reduces parameters by 48.17%, computational load by 59.26%, and model size by 41.94%, while significantly decreasing classification and regression errors, and false positives/negatives. YOLOv8n-DE offers outstanding performance and lightweight advantages for citrus disease detection, supporting precision agriculture development in orchards.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.